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chains. The  subunit binds the Fc portion of a single
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for mediating signal transduction events via their immu-
noreceptor tyrosine-based activation motifs (ITAMs),
Janet Kalesnikoff,1 Michael Huber,3
Vivian Lam,1 Jacqueline E. Damen,1
Juan Zhang,2 Reuben P. Siraganian,2
and Gerald Krystal1,4
1The Terry Fox Laboratory
British Columbia Cancer Agency which, upon phosphorylation by members of the Src
kinase family, attract Src-homology-2 (SH2)-containing601 West 10th Avenue
Vancouver, British Columbia V5Z 1L3 signaling proteins (Turner and Kinet, 1999). IgE binding
to the FcRI is referred to as a “passive presensitization”Canada
2 Receptors and Signal Transduction Section step in the current mast cell signaling paradigm. FcRI
activation and signaling is thought to occur only whenOral Infection and Immunity Branch
National Institute of Dental and receptor-bound IgE is crosslinked via multivalent anti-
gens (Ags) (Beaven and Metzger, 1993; Kinet, 1999).Craniofacial Research
National Institutes of Health We recently demonstrated that IgE binding, in the
absence of Ag, triggered a number of signaling path-Bethesda, Maryland 20892
3 Department of Molecular Immunology ways in normal murine bone marrow-derived mast cells
(BMMCs) (Huber et al., 1998a). We also showed that anBiology III
University of Freiburg and important function of the SH2-containing inositol phos-
phatase SHIP in these cells was to prevent this signalingMax-Planck-Institute for Immunobiology
Stuebeweg 51 from progressing to degranulation, by hydrolyzing the
IgE-induced generation of phosphatidylinositol (PI)-79108 Freiburg
Germany 3,4,5-P3. In the present study, we have further elucidated
the signaling events triggered by IgE alone and the bio-
logical ramifications of these signaling events.
Summary
Results
Although IgE binding to mast cells is thought to be a
passive presensitization step, we demonstrate herein IgE Alone Stimulates the Phosphorylation of the Erks,
that monomeric IgE (mIgE) in the absence of antigen p38, JNK, and PKB in Normal Murine BMMCs
(Ag) stimulates multiple phosphorylation events in nor- We recently reported that a 3 min exposure to 5 g/ml
mal murine bone marrow-derived mast cells (BMMCs). IgE in the absence of Ag triggered the phosphorylation
While mIgE does not induce degranulation or leuko- of the FcRI  and  subunits, Shc, and SHIP in normal
triene synthesis, it leads to a more potent production murine BMMCs and that the presence of SHIP prevented
of cytokines than IgE  Ag. Moreover, mIgE prevents IgE-induced signaling from progressing to degranula-
the apoptosis of cytokine-deprived BMMCs, likely by tion (Huber et al., 1998a). To further explore the signaling
maintaining Bcl-XL levels and producing autocrine- potential of IgE with normal BMMCs, we carried out time
acting cytokines. The addition of Ag does not increase course studies with IgE alone (monoclonal anti-DNP
this IgE-induced survival. Since IgE concentrations as clone SPE-7 IgE, Sigma) and examined the phosphoryla-
low as 0.1 g/ml enhance BMMC survival, elevated tion of the mitogen-activated protein kinases, Erk 1/2,
plasma IgE levels in humans with atopic disorders may p38 (a.k.a. HogK), and JNK (a.k.a. SAPK). As can be
contribute to the elevated mast cell numbers seen in seen in Figure 1A, 5 g/ml of IgE alone stimulated near
these individuals. maximal phosphorylation of the Erks within 5 min, and
this phosphorylation was still at maximal levels at 60
Introduction min of stimulation. The stress-activated kinases, p38
and JNK, were also phosphorylated in response to IgE
IgE-induced mast cell activation is responsible for both alone, with p38 again being maximally phosphorylated
allergic disorders, such as hay fever and asthma, and within 5 min of stimulation and remaining at maximal
for host resistance to parasites via the secretion of proin- levels following 60 min of exposure. Interestingly, JNK
flammatory mediators (Schwartz, 1994; Yamaguchi et phosphorylation was relatively delayed, not peaking un-
al., 1999; Galli, 2000). The three major classes of pro- til 15 min poststimulation. In addition, as shown in Figure
inflammatory mediators released by these cells are pre- 1B, IgE alone stimulated the phosphorylation of the sur-
formed granule-associated chemical mediators, newly vival-enhancing kinase PKB at both Ser473 and Thr308.
synthesized arachidonic acid metabolites, and cyto- This dual phosphorylation, which is required for full acti-
kines (Schwartz, 1994; Mekori and Metcalfe, 2000). IgE vation of PKB (Alessi et al., 1997), indicated that IgE
initiates these processes by binding to mast cells via alone was also capable of recruiting PI-3-kinase to the
the high-affinity receptor FcRI, which belongs to the plasma membrane, since PI-3-kinase is upstream of
immune receptor superfamily and exists as a tetramer PKB phosphorylation and generates PI-3,4,5-P3 at the
plasma membrane to attract the PH-containing kinases,
PDK-1 and PKB (Alessi et al., 1997). A reprobing of the4 Correspondence: gerryk@terryfox.ubc.ca
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Figure 1. IgE in the Absence of Ag Stimulates Multiple Phosphorylation Events
BMMCs were treated with 5 g/ml IgE alone for the indicated times, and the SDS-solubilized total cell lysates were subjected to (A) Western
analysis with phospho-specific antibodies to Erk 1/2 (left panel), p38 (middle panel), or JNK (right panel). The blots were then reprobed with
antibodies to Erk 1, p38, and JNK, respectively, to confirm equal loading. (B) Western analysis was performed with anti-phospho-Ser473-
specific PKB (top panel) and reprobed with anti-phospho-Thr308-specific PKB (middle panel) and anti-PKB (to confirm equal loading; bottom
panel). (C) BMMCs, treated with 5 g/ml IgE alone for the indicated times or 5 g/ml IgE for 4 hr and then 20 ng/ml DNP-HSA for the indicated
times, were SDS solubilized, and total cell lysates were subjected to Western analysis with anti-phospho-specific Erk 1/2 (upper panel) and
then anti-Erk 1 antibodies (lower panel). Results are representative of six separate experiments. (D) BMMCs, treated as in (C), were lysed with
TX-100 and subjected to immunoprecipitation with anti-phosphotyrosine (4G10) beads and Western analysis with anti-FcRI  chain antibodies.
Results are representative of three separate experiments.
blots shown in Figures 1A and 1B with anti-Erk1, anti- when the cells were preloaded overnight, ruling out that
the similar intensities were due simply to a transientp38, anti-JNK, and anti-PKB, respectively, established
equal loading. desensitization by IgE (data not shown).
Having established that signaling events are initiatedSince it had been reported previously that IgE  Ag
triggers the phosphorylation of these same signaling by IgE alone and with a similar intensity to that elicited
with IgE  Ag when 5 g/ml IgE is used, we comparedintermediates (Lu-Kuo et al., 2000), we compared the
intensity and kinetics of phosphorylation of the Erks and the tyrosine phosphorylation of the FcRI itself. BMMCs
were stimulated as above and the cell lysates subjectedPKB in response to IgE alone versus IgE  Ag (DNP-
HSA). As shown with Erk 1/2 in Figure 1C, we found that to immunoprecipitation with anti-phosphotyrosine beads
and Western analysis with anti-FcRI  subunit antibod-phosphorylation events were slightly delayed but far
more prolonged in response to IgE alone. Specifically, ies (Figure 1D). Interestingly, phosphorylation of the
FcRI  chain by IgE alone was less intense than that5g/ml of IgE for 4 hr, followed by an optimal concentra-
tion of Ag (20 ng/ml) for the indicated times, triggered observed in response to IgE  Ag, but phosphorylation
levels remained clearly detectable at 4 hr (i.e., the zeroa maximal phosphorylation of the Erks by 2 min, but
this phosphorylation was barely detectable at 15 min time for IgE  Ag). With IgE  Ag, on the other hand,
phosphorylation of the FcRI  chain was clearly fasterand was back to baseline levels by 1 hr. With 5 g/ml
IgE alone, on the other hand, Erk 1/2 phosphorylation and more intense, peaking at 2 min but returning to its
baseline levels by 1 hr.was barely detectable at 2 min, peaked at 15 min, re-
mained clearly visible at 2 hr, and was back to baseline
levels at 4 hr (the zero time for IgE  Ag). Similar results IgE Alone Likely Acts through the FcRI
and Lipid Raftswere obtained with PKB (data not shown). Worthy of
note is that the level of Erk 1/2 phosphorylation stimu- We then carried out IgE dose response studies  Ag,
using Erk phosphorylation as an endpoint. As can belated by 5 g/ml IgE alone was similar to that attained
with 5 g/ml IgE  Ag. Similar results were obtained seen in Figure 2A, 2–5 g/ml of IgE (for 60 min) was
IgE Alone Enhances Mast Cell Survival
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Figure 2. Monomeric IgE Stimulates Erk
Phosphorylation
(A) BMMCs, treated with the indicated con-
centrations of IgE alone for 60 min or the
indicated concentrations of IgE for 4 hr and
then 20 ng/ml Ag for 2 min, were SDS solubi-
lized, and total cell lysates were subjected to
Western analysis with anti-phospho-specific
Erk 1/2 (upper panel) and then anti-Erk 1
(lower panel). Results are representative of
two separate experiments.
(B) Clone SPE-7 anti-DNP IgE (Sigma) was
fractionated using a BioSep SEC S3000 col-
umn (left panel) and the monomer peak either
rechromatographed immediately (middle panel)
or after incubation for 7 days at 37C in Tyrode’s
buffer (right panel). Results are representative
of ten separate experiments.
(C) BMMCs were treated with 5 g/ml unfrac-
tionated IgE, HPLC buffer eluate (B), 5 g/ml
mIgE, 5 g/ml mIgE  0.5 g/ml aggregates
(agg), or 0.5 g/ml aggregates alone for the
indicated times, SDS solubilized, and sub-
jected to Western analysis with anti-phospho
Erk 1/2. The blot was reprobed with anti-Erk
1 to demonstrate equal loading. Results are
representative of two separate experiments.
required for maximal Erk phosphorylation, whereas only by an IgE ELISA), aggregates alone (at the level present
in 5 g/ml of unfractionated IgE, i.e., 0.5 g/ml), or ag-0.01g/ml of IgE was required for maximal phosphoryla-
tion when a 4 hr pretreatment with IgE was followed gregates plus 5g/ml mIgE were tested. As can be seen
in Figure 2C, 5 g/ml mIgE could still robustly stimulatewith 2 min of 20 ng/ml Ag. Densitometric analyses of
these two blots suggested an EC50 of 1 g/ml for IgE the phosphorylation of Erk 1/2. While this stimulation
was slightly reduced compared to unfractionated IgE,alone and 0.005 g/ml for IgE  Ag. Similar results were
obtained with RBL-2H3 cells (data not shown). This 200- the aggregates were very poor stimulants, and the addi-
tion of aggregates to mIgE did not increase the responsefold difference in potency raised the possibility that IgE
alone was stimulating these cells because of a small over that seen with mIgE alone (Figure 2C). These results
suggest that the aggregates in these commercial prepa-number of aggregates in the commercial IgE anti-DNP
preparation. To test this, we fractionated this Sigma IgE rations of IgE are for the most part in inactive conforma-
tions. Of note, column eluate alone did not stimulatevia BioSep SEC S3000 gel filtration HPLC and found,
depending on the lot number, that these anti-DNP IgE Erk phosphorylation (Figure 2C). We also assessed the
levels of endotoxin in both our unfractionated and HPLCpreparations contained from 5% to 20% aggregates
(dimers plus higher molecular weight aggregates) (Fig- purified IgE preparations, since endotoxin has been
shown to stimulate mast cells (Leal-Berumen et al.,ure 2B, left panel). The purified monomers were rechro-
matographed immediately following purification (Figure 1994). Using the highly sensitive LAL reagent clotting
assay (Sullivan et al., 1983), we found the level of endo-2B, middle panel), 7 days after incubation at 37C in
Tyrode’s buffer (Figure 2B, right panel) or 1 year after toxin was below the limit of detection (1.25 pg/ml). Con-
centrations up to 106-fold higher than this had no effectstorage in PBS at 4C (data not shown) and in all cases
remained in the monomeric state (i.e., contained less on Erk phosphorylation.
The 200-fold difference in potency between IgE alonethan 0.5% aggregates, our lower limit of detection). To
determine if the IgE-induced Erk phosphorylation was and IgE  Ag also raised the possibility that IgE alone
was acting through a low-affinity IgE receptor. Of thedue to the presence of these aggregates, freshly pre-
pared monomeric IgE (mIgE) (at 5 g/ml, as assessed known low-affinity IgE receptors on BMMCs, the most
Immunity
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Figure 3. IgE Likely Acts through the FcRI and Lipid Rafts
(A) BMMCs were pretreated  10 g/ml of 2.4G2 or isotype control (rat IgG2b anti-Mac1) antibody for 30 min at 4C and then either left
unstained or exposed to 30 g/ml heat-aggregated (63C, 30 min [pH 8]; Daeron et al., 1980) FITC-mouse IgG for 30 min at 4C and subjected
to FACS analysis. The first panel shows the unstained control, the second panel shows the nonpretreated FITC-IgG sample, the third panel
shows the 2.4G2 pretreated sample, and the fourth panel shows the isotype control pretreated sample. (B) BMMCs were either pretreated 
10 g/ml 2.4G2 for 30 min at 4C and then treated  5 g/ml IgE for 15 min (left panel) or pretreated  25 mM lactose for 10 min at 37C
and then treated  5 g/ml IgE for 15 min (right panel). (C) BMMCs were pretreated for 15 min  1.6 g/ml filipin III (F) or 7 mM methyl--
cyclodextrin (M) and then treated  5 g/ml IgE or 20 ng/ml DNP-HSA for 5 min. Results are representative of two separate experiments.
likely candidate, given that IgE alone stimulates the raft disrupters filipin III (Aman and Ravichandran, 2000)
and methyl--cyclodextrin (Vereb et al., 2000) on IgE-phosphorylation of the  subunit of FcRI, was FcRIII.
Although FcRIII is expressed at relatively low levels at induced Erk phosphorylation. As can be seen in Figure
3C, both markedly inhibited IgE-induced Erk phosphory-the surface of BMMCs (Katz and Lobell, 1995), it also
utilizes this  subunit (Kurosaki et al., 1992) and has lation. This suggests that signaling induced by IgE alone,
like IgE  Ag (Holowka et al., 2000), involves a criticalbeen shown to be a low-affinity receptor for both IgG and
IgE (Takizawa et al., 1992). To test this, we preincubated detergent-resistant membrane (DRM) step.
BMMCs with the FcRIII/FcRII blocking antibody 2.4G2
(Unkeless, 1979) under conditions which completely IgE Alone Is More Effective than IgEAg at Increasing
the Levels of Multiple Cytokinesblocked binding to these receptors (Figure 3A) and
found that it had no effect on subsequent IgE-induced Since stimulating normal BMMCs with IgE  Ag has
been shown to trigger mast cell degranulation, the gen-Erk phosphorylation (Figure 3B, left panel). Another low-
affinity IgE receptor that has been shown to be present eration of arachidonic acid metabolites, and the synthe-
sis of various cytokines (Mekori and Metcalfe, 2000), weon the rat basophilic cell line, RBL-2H3 (Frigeri and Liu,
1992), and thus may be present on BMMCs is the lectin compared the ability of IgE alone with IgE  Ag at elic-
iting these three biological responses. Specifically, weMac-2 (a.k.a. BP). This receptor binds to -galactoside
on the cell surface and thus can be efficiently eluted compared -hexosaminidase release to monitor de-
granulation, LTC4 production (using enzyme immunoas-from cells with 25 mM lactose (Frigeri and Liu, 1992).
However, this treatment did not diminish IgE-induced says [EIAs]) to monitor arachidonic acid metabolite pro-
duction, and cytokine mRNA levels via RNase protectionErk phosphorylation (Figure 3B, right panel). These re-
sults suggest that IgE alone triggers Erk phosphorylation assays (RPAs). As expected, IgE  Ag stimulated all
three responses (Figure 4). Surprisingly, however, whilethrough the FcRI.
To gain some insight into how IgE alone triggers these IgE alone was incapable of triggering degranulation or
significant LTC4 release (Figure 4A), it dramatically in-signaling events, we examined the effects of the lipid
IgE Alone Enhances Mast Cell Survival
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Figure 4. IgE Increases Multiple Cytokine mRNA and Protein Levels More than IgE  Ag
BMMCs, treated  10 g/ml IgE (filled boxes) for the indicated times or 10 g/ml IgE for 4 hr and then 20 ng/ml DNP-HSA (empty boxes) for
the indicated times, were analyzed for (A) degranulation (left panel) and LTC4 production (right panel). The values shown in the left panel are
the means  SEM of duplicate determinations, and both panels are representative of three separate experiments. (B) BMMCs, treated with
IgE for 15 min at the indicated concentrations (in g/ml) were subjected to RNase protection assays (Riboquant), and relative band intensities
of IL-6, TNF, IL-4, and IL-13 were quantitated using a phosphoimager and standardized using levels of the housekeeping gene GAPDH.
Results are representative of four separate experiments. (C) BMMCs, treated with 5 g/ml IgE for the indicated times or 5 g/ml IgE for 4 hr
and then washed three times and exposed to 20 ng/ml DNP-HSA for the indicated times, were subjected to RNase protection assays as in
(B). Results are representative of four separate experiments. The inset shows the levels of IL-6 protein (assessed by IL-6 ELISA) in medium
conditioned by BMMCs treated as in (C). The last two lanes show the level of IL-6 secreted by 3 hr in response to 5 g/ml mIgE or 0.5 g/
ml aggregates. Values are the mean  SEM of eight determinations (duplicates of four separate experiments). (D) BMMCs were treated with
the indicated concentrations of IgE for 24 hr, and the levels of secreted IL-6 were determined. (E) LY294002 (LY) at 50 M, 50 M PD98059
(PD), and 10 M SB203580 (SB) were added to BMMCs 30 min before the addition of 5 g/ml IgE or 20 ng/ml DNP-HSA, and the production
of IL-6 was assessed after 3 hr of incubation. Values for (D) and (E) are the mean  SEM of duplicate determinations and are representative
of two separate experiments.
creased the mRNA levels of multiple cytokines (e.g., due to a differential secretion of proteases or protease
inhibitors. Also of note, mIgE was only slightly less po-IL-6, TNF, IL-4, and IL-13) in a dose-dependent manner
(Figure 4B). In fact, IgE alone was substantially more tent than unfractionated IgE, while IgE aggregates were
very poor stimulators of cytokine secretion (inset to Fig-potent than IgE  Ag at increasing the mRNA levels of
these cytokines. A typical result, shown with IL-6 mRNA, ure 4C). To ensure that our HPLC purification did not
inactivate the IgE aggregates, we repeated our IL-6 se-is depicted in Figure 4C. Reminiscent of our protein
phosphorylation data (Figure 1C), cytokine mRNA levels cretion studies with monomeric and aggregate-enriched
preparations obtained via a 60 min airfuge procedure.remained elevated longer in response to IgE alone than
IgE  Ag (Figure 4C). However, this was not true for Bearing in mind the caveat that this procedure only
removes larger aggregates, we found, once again, thatall cytokines examined. IL-5 mRNA levels, for example,
were substantially higher following IgE  Ag than IgE all the IgE-induced production of IL-6 could be attrib-
uted to mIgE (data not shown).alone (data not shown).
To determine if cytokine levels secreted by BMMCs Interestingly, while IgE-induced IL-6 mRNA levels
peaked at 60 min, IL-6 protein levels did not reach pla-in response to IgE alone versus IgE Ag paralleled their
mRNA levels, we compared IL-6 protein levels, by ELISA, teau levels until 3 hr, and this discrepancy could sug-
gest, as has been shown with TNF production fromin medium conditioned by BMMCs. As shown in the
insert in Figure 4C, this was indeed the case, with se- RBL-2H3 cells (Baumgartner et al., 1994), that secretion
from BMMCs is actively regulated via a calcium- andcreted IL-6 levels being 5- to 10-fold higher following
stimulation with IgE alone than with IgE  Ag. Similar PKC-mediated pathway and that this pathway may be
more active in response to IgE alone. An IgE dose re-results were obtained with IL-13 and TNF (data not
shown). Of note, identical results were obtained when sponse study was then carried out and revealed a similar
EC50 for IL-6 (and IL-13; data not shown) secretion (Fig-a protease inhibitor cocktail was added to the medium
(Sigma, P-8340), suggesting that this difference is not ure 4D) to that seen for Erk phosphorylation.
Immunity
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Figure 5. IgE Alone Maintains Bcl-XL Levels and Prevents Apoptosis of BMMCs
(A) BMMCs derived from four separate mice were incubated separately for 72 hr with 10% FCS alone (closed squares) or plus 5 g/ml IgE
(closed triangles), 40 ng/ml SF (open circles), or 30 ng/ml IL-3 (open triangles) and viable cells counted. Values are the mean  SEM of eight
determinations (duplicates for the four BMMC preparations). (B) BMMCs were incubated for 48 hr with 10% FCS alone (C) or plus 30 ng/ml
IL-3 or 5 g/ml IgE, and the DNA was then extracted and subjected to agarose gel electrophoresis. 1 kb 	 1 kb DNA ladder (GIBCO-BRL).
Results are representative of two separate experiments. (C) BMMCs were cultured for 24 hr with 10% FCS alone (C) or plus 30 ng/ml IL-3 or
10 g/ml IgE, and total cell lysates were subjected to Western analysis with anti-Bcl-XL and reprobing with anti-Shc antibodies to show equal
loading. Results are representative of three separate experiments. (D) Representative FACS profiles of CFSE-stained BMMCs after 3 days of
culture in 10% FCS alone (top panel), 30 ng/ml IL-3 (middle panel), or 10g/ml IgE (bottom panel). The inset in the top panel shows [3H]thymidine
incorporation after a 6 hr labeling on day 3, with 1 Ci/50,000 cell sample (2 Ci/mmole), and each point is the mean  SEM of three
determinations.
To gain some insight into the pathways involved in and Berger, 1998). Similar results were obtained with a
hybridoma supernatant from a different IgE (i.e., anti-eliciting this robust production of inflammatory cyto-
kines, BMMCs were stimulated with IgE alone or IgE  erythropoietin IgE-26), at a final concentration of 10
g/ml (StemCell Technologies Inc., Vancouver, BC), butAg for 3 hr  the PI-3-kinase inhibitor LY294002, the
MEK inhibitor PD98059, or the p38 inhibitor SB203580. not from an equal volume of an IgG1-producing hybrid-
oma supernatant produced in the same medium (i.e.,As can be seen in Figure 4E, all three inhibitors blocked
IL-6 production, suggesting that the PI-3-kinase, Erk, anti-glycophorin A at 20 g/ml; StemCell Technologies
Inc.) (data not shown), ruling out the possibility that theand p38 pathways all play a role in mediating IgE- as well
as IgE  Ag-induced cytokine production/secretion. Of purification procedure used in producing the commer-
cial anti-DNP IgE altered its properties. Moreover, wenote, these inhibitors did not affect cell viability at the
concentrations used, even after 24 hr of incubation with observed equally potent IgE-induced survival of BMMCs
from both C57B6 and Balb/C mice, indicating that ourIgE-stimulated BMMCs (data not shown).
results are not mouse strain specific.
To determine if IgE was enhancing survival by pre-IgE Enhances Mast Cell Survival and Does
So by Preventing Apoptosis venting apoptosis, DNA was isolated from BMMCs fol-
lowing 48 hr of incubation  5 g/ml IgE or 30 ng/mlSince PKB, the Erks, and the cytokines IL-4, IL-6, and
IL-13 have all been shown to enhance survival in some IL-3. As can be seen in Figure 5B, IgE alone was as
effective as IL-3 at preventing DNA fragmentation. Tocell systems (Downward, 1998; Deng et al., 2000; Yana-
gida et al., 1995; Lai and Mosmann, 1999), we asked if gain some insight into the mechanism(s) underlying
IgE’s ability to prevent apoptosis, we compared the lev-IgE alone might be a prosurvival factor for BMMCs. As
can be seen in Figure 5A, a 48 hr incubation of these cells els of the antiapoptotic protein Bcl-XL in BMMCs, follow-
ing 24 hr of incubation  IgE or IL-3. As shown in Figurewith 5 g/ml IgE alone was as effective at preventing
cell death as maximal levels of IL-3 or SF, two well- 5C, IgE, like IL-3, prevented Bcl-XL levels from falling to
that seen in starved cells. For this study, a 24 hr timedocumented mast cell survival factors (Gommerman
IgE Alone Enhances Mast Cell Survival
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point was chosen to ensure that all the cells in the
starved culture were still viable. An anti-Shc reprobing
of the blot confirmed equal loading of the gel. The main-
tenance of this prosurvival Bcl-2 family member sug-
gests at least one pathway by which IgE may be pre-
venting BMMC death.
To determine if IgE was acting primarily as a survival
factor or a mitogen, we carried out both [3H]thymidine
incorporation and CFSE vital dye (Glimm and Eaves,
1999) studies. As can be seen in the inset to Figure 5D,
a 6 hr labeling of BMMCs, following 3 days with IgE, IL-3,
or control medium, revealed that IL-3-containing cultures
incorporated substantial levels of thymidine, while IgE-
containing cultures did not. At this time, there were 4.0
(IgE), 1.8 (control), and 6.25 (IL-3) 
 105 viable BMMCs/
ml. BMMCs were also stained with 5 M CFSE, flow
cytometry sorted to obtain a homogeneous population
of stained cells, and incubated for 3 days  IL-3 or IgE.
Similar to our [3H]thymidine results, the CFSE results
suggested that IgE is primarily a survival factor (Fig-
ure 5D).
Freshly prepared mIgE was also tested for its effect
on BMMC survival. Dose response studies revealed that
concentrations as low as 0.1 g/ml were capable of
significantly enhancing survival (Figure 6A). IgE aggre-
gates, on the other hand, at 0.5 g/ml, were found to be
relatively poor enhancers of survival (i.e., approximately
equal to 0.1 g/ml monomeric IgE; Figure 6A). This
strongly suggested that, if there were low levels of con-
taminating IgE aggregates in our mIgE preparations, Figure 6. Monomeric IgE Enhances Mast Cell Survival
they were not playing a significant role in enhancing (A) BMMCs were cultured with 10% FCS alone (closed squares) or
BMMC survival. Also of interest was our finding that plus 0.1 (open diamonds), 1 (open triangles), 5 (closed circles), or
10 (closed triangles) g/ml mIgE or plus 0.5 g/ml IgE aggregatesmIgE did not have to synergize with factors in FCS to
(open squares), and viable cells were counted on the days indicated.enhance survival, since similar survival enhancement
(B) BMMCs were cultured with 10% FCS alone (closed squares) orwas observed with medium containing 0.1% BSA in-
plus 0.1, 1, or 5 g/ml mIgE in the presence (open diamonds, openstead of 10% FCS (data not shown). Interestingly, no
triangles, open circles) and absence (closed diamonds, closed trian-
enhancement in BMMC survival was observed when Ag gles, closed circles) of 20 ng/ml DNP-HSA. Viable cell counts were
was added to 5 g/ml mIgE (Figure 6B). However, it was determined on the days indicated. For (A) and (B), the values shown
are the mean SEM of duplicate determinations, and similar resultsconceivable that we were already at the maximal levels
were obtained in two separate experiments.of survival attainable and so carried out mIgE dose re-
sponse studies  Ag and again found no enhancement
of survival (Figure 6B). similar (data not shown). This suggests that exposure
to IgE for 4 hr is sufficient to enhance survival.
Finally, to see if the autocrine-acting factors could beThe Autocrine Production of Cytokines Contributes
to IgE-Induced BMMC Survival the cytokines produced in response to IgE, we added
a combination of cytokines (i.e., IL-2, IL-3, IL-4, IL-6,To determine if cells cultured in the presence of mIgE
were producing cytokines or other factors that contrib- IL-13, and TNF) to BMMCs cultured in the absence
(Figure 7B) or presence (Figure 7C) of 0.5 g/ml IgE.uted to the enhancement of BMMC survival, medium
conditioned by a 3 day incubation of BMMCs with mIgE The cytokine concentrations used were based either on
levels in conditioned media from 3 day IgE-stimulated(10 g/ml) was treated with DNP-agarose beads to re-
move the IgE. This purged conditioned medium, which BMMCs cultures (for IL-3, IL-6, and TNF, based on
ELISAs) or from extrapolating RPA results (for IL-2, IL-4,retained 0.5 g/ml of IgE (sample 3 in inset in Figure
7A), was then added to naive BMMCs and survival moni- and IL-13). As can be seen in Figure 7B, these cytokines
significantly enhanced BMMC survival, although to atored. As can be seen in Figure 7A, this conditioned
medium enhanced survival to the same degree as me- lesser degree than that achieved with 10 g/ml IgE (sur-
vival in the presence of 0.5 g/ml IgE alone is showndium containing 10g/ml IgE. Thus, IgE-stimulated cells
were producing autocrine-acting factors that were suffi- as a dashed line to compare to Figure 7C). However, as
shown in Figure 7C, the combination of these cytokinescient to mediate the IgE-induced cell survival. This was
also suggested by our finding that IgE-induced survival with 0.5 g/ml IgE yielded a survival equal to that ob-
tained with 10 g/ml IgE, at least for the first 3 days ofwas cell density dependent (data not shown). Interest-
ingly, if BMMCs were treated with 10 g/ml IgE for only culture. The subsequent drop in survival could be due
to the omission of either one or more secreted cytokines4 hr and the cell medium treated with or without DNP-
agarose and added back to the cells, the survival was or certain noncytokine secreted factors.
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kines than IgE  Ag in primary murine BMMCs. More-
over, we show that IgE alone enhances the survival
of these BMMCs and does so, at least in part, via
the secretion of autocrine-acting cytokines. This chal-
lenges, to some extent, the current paradigm, which
states that binding of IgE to FcRI is a passive presensiti-
zation step that does not lead to intracellular signaling
unless receptors are subsequently crosslinked (Beaven
and Metzger, 1993). Our findings are not totally unprece-
dented, however, since earlier studies have shown that
IgE alone increases FcRI expression both in vitro and
in vivo in mouse and human mast cells (Hsu and Mac-
Glashan, 1996; MacGlashan et al., 1997; Yamaguchi et
al., 1997, 1999), and this upregulation consists of an
initial protection from internalization/degradation phase
and a subsequent cyclohexamide-sensitive upregula-
tion phase (Yamaguchi et al., 1997). Importantly, our
results are not totally in conflict with the current para-
digm, since they are still consistent with signaling being
mediated via aggregation of FcRI. Related to this, while
our studies with 2.4G2 and lactose strongly suggest that
mIgE is initiating signaling via FcRI, future experiments
with BMMCs from FcRI-deficient mice will be required
to confirm this.
To address the major question of how IgE alone is
stimulating BMMCs, it is highly unlikely that the aggre-
gates in the commercial IgE anti-DNP preparations are
responsible, since they are very poor stimulators of Erk
phosphorylation, IL-6 production, and survival. Even if
trace amounts of active aggregates are present in our
mIgE preparations, more should be present in our aggre-
gate preparations, and yet we always observe far less
activity in them. Given the extensive evidence in the
literature, we favor a model in which mIgE activates
BMMCs by triggering FcRI aggregation. The only ques-
tion is whether mIgE does this by first aggregating in
solution within the BMMC milieu, perhaps in response
to cell-secreted factors, and then binding to the FcRI
or by binding to the FcRI first and then triggering aggre-
gation. Against the former, we do not see any detectable
Figure 7. IgE-Induced Cytokines Act in an Autocrine Manner to En- aggregation upon storage of mIgE in PBS or in medium
hance BMMC Survival containing 0.1% BSA (the medium in which we stimulate
(A) BMMCs were cultured with 10% FCS alone (closed squares) or BMMCs with mIgE), and we do not see any increased
plus 0.5 g/ml mIgE (closed circles), 10 g/ml mIgE (closed trian-
activity when we preincubate mIgE with BMMCs (datagles), 3 day conditioned medium (open triangles), or 3 day condi-
not shown). We thus favor a model in which mIgE bindstioned medium treated with DNP-agarose to reduce IgE levels to
to the FcRI and reduces, to a modest extent, given its0.5 g/ml (open circles), and viable cells were counted on the days
indicated. The inset in (A) shows IgE levels in fresh medium con- EC50 of 1 g/ml, an inherent repulsion between neigh-
taining 10 g/ml IgE (1) and in this same medium following 3 days boring receptors, allowing them to slowly form small
of incubation with BMMCs before (2) and after (3) treatment with clusters in lipid rafts and trigger a low but prolonged signal-
DNP-agarose. (B) BMMCs were cultured with 10% FCS alone ing of various intracellular pathways. Relevant to the con-
(closed squares) or plus 0.5 g/ml mIgE (closed circles), 10 g/ml
cept of IgE reducing an inherent repulsion between neigh-mIgE (closed triangles), or a combination of 500 pg/ml IL-2, 10 pg/
boring FcRI, we found in our survival studies with variousml IL-3, 500 pg/ml IL-4, 5 ng/ml IL-6, 5 ng/ml IL-13, and 2.5 ng/ml
IgE-producing hybridomas that the supernatants fromTNF (open triangles), and viable cells were counted on the days
indicated. (C) BMMCs were cultured with 10% FCS alone (closed three different IgE-anti-DNP hybridomas were more po-
squares) or plus 0.5 g/ml mIgE (closed circles), 10 g/ml mIgE tent (based on IgE ELISAs) than those of five other IgE-
(closed triangles), or a combination of the same cytokines as in (C) producing hybridomas. On the other hand, one IgE to
plus 0.5 g/ml mIgE (open triangles), and viable cells were counted an as yet unknown epitope was even more potent than
on the days indicated. Values for (A), (B), and (C) are the mean 
the IgEs against DNP. This suggests perhaps that theSEM of duplicate determinations, and similar results were obtained
charge/conformation within the Fab hypervariable re-in two separate experiments.
gion of IgE influences its ability to aggregate FcRI.
Related to this, IgE-anti-Epo26 was significantly less
Discussion potent than IgE-anti-DNP at inducing IL-6 secretion, and
this correlated with a reduced ability to enhance survival.
We demonstrate herein that IgE alone triggers multiple Interestingly, adding DNP-lysine to BMMCs 1 hr after
the addition of mIgE-anti-DNP abruptly halted IL-6 se-signaling pathways and a more robust secretion of cyto-
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cretion. Addition of DNP-lysine to IgE-anti-Epo, on the PKC-dependent secretion step, independent of protein
other hand, had no effect, ruling out nonspecific inhibi- synthesis, that determines the release of TNF from RBL-
tion. This is consistent with a model in which the binding 2H3 cells. It is thus possible that IgE alone, perhaps
of DNP-lysine to IgE abrogates the ability of IgE to re- because of its prolonged signaling, stimulates the re-
duce the inherent repulsion between neighboring IgE lease of IL-6 for a longer period of time than IgE  Ag.
receptors and both prevents the formation of and dis- Related to this, these authors found that the addition
rupts IgE/FcRI cell surface aggregates. This is both of DNP-lysine 1 hr after the addition of DNP-BSA, to
compatible with and sheds new light on early studies disaggregate the residual cell surface complexes, imme-
in which DNP-lysine was used to disrupt signaling initi- diately halted secretion (and promoted intracellular deg-
ated by DNP-albumin-induced aggregates (e.g., Kawa- radation of TNF). This suggests that a continuous Ag-
kami et al., 1992). We also found that if we washed mIgE- induced signal is required to maintain secretion. As to
treated BMMCs free of mIgE after 1 hr and then added the identity of the cytokine(s) that enhances IgE-induced
DNP-lysine to the cells, it still abruptly halted IL-6 secre- BMMC survival, we assessed the level of SF in medium
tion. This suggests that DNP-lysine is disrupting aggre- conditioned by 3 days with IgE, since de Paulis et al.
gates at the cell surface rather than in solution, and (1999) showed that SF is released from human mast
this effect is consistent with IgE triggering signaling via cells. However, it was below the limit of detection of the
receptor aggregation. ELISA (less than 250 pg/ml), and levels of neutralizing
As to why IgE alone stimulates cytokine secretion to anti-SF that could inhibit 30 ng/ml of SF from enhancing
a much greater extent than IgE  Ag but is incapable BMMC survival did not reduce the survival effects of
of triggering degranulation or LTC4 production, it is pos- IgE. Thus, SF does not appear to be an important player
sible that intensity and kinetic differences in signaling in IgE-induced BMMC survival.
are responsible. Thus, while we cannot rule out qualita- An important outstanding issue, of course, is whether
tive differences, it may not be necessary to invoke them. IgE alone enhances mast cell survival in mice. In this
IgEAg triggers a much more rapid and robust tyrosine regard, it has been known for some time that serum IgE
phosphorylation of the receptor  subunit and more levels are elevated in patients with allergic disorders or
rapid Erk phosphorylation, and this higher signaling in- parasitic infections (Bennich and Johansson, 1970) and
tensity early on may allow several signals to converge correlate with both disease severity and protective im-
with sufficient intensity to surpass the threshold for de- munity to parasites (Corry and Kheradmand, 1999). This
granulation and leukotriene production. The weaker, can be explained, at least in part, by the finding that
longer lasting signal triggered by IgE alone, due perhaps mast cells undergo IgE-dependent FcRI upregulation,
to the relatively unsynchronized, slow on rate of IgE and this enables the cells to bind more IgE and thus be
(Kulczycki and Metzger, 1974), the possible requirement activated to release mediators with lower concentra-
for a sufficient saturation of receptors to facilitate IgE- tions of a given antigen (Galli, 2000; Kinet, 1999; Yama-
IgE aggregation, and/or the far slower internalization guchi et al., 1997, 1999). Our results suggest that ele-
rate of uncrosslinked IgE/FcRI (Mao et al., 1993) may vated levels of IgE may also be stimulating the release
play a pivotal role in allowing cytokines to be actively of inflammatory cytokines. While this cytokine release
secreted from BMMCs. Related to this, Kawakami et al. may not lead, in the absence of degranulation and leuko-
(2000) recently proposed that the enhanced secretion triene production, to an inflammatory response by itself
of TNF and IL-2 they observe in IgE  Ag-stimulated in vivo, it may contribute to a subsequent, Ag-initiated
Lyn-deficient BMMCs might be due to a prolonged acti- inflammatory response. As well, since the concentration
vation of the Erks and JNK. of IgE that promotes survival in our BMMC assay (0.1–10
As to how the prolonged signals we observed with
g/ml) is present in mouse and human sera exposed to
IgE alone might lead to maintenance of Bcl-XL and more parasites and allergens (Bennich and Johansson, 1970),
cytokine production, the Erks have been shown to play it may be responsible, at least in part, for the elevated
an antiapoptotic role in some cell types (e.g., Deng et al.,
numbers of mast cells observed under these circum-
2000), and PKB is a well-established prosurvival kinase
stances.
(Downward, 1998). PKB activation leads, among other
things, to the activation of NFAT, which is a well-known Experimental Procedures
activator of cytokine gene expression in mast cells (Ki-
taura et al., 2000), and NFB (Ozes et al., 1999), which Mast Cell Isolation
Bone marrow cells aspirated from 4- to 8-week-old C57B6 miceupregulates the synthesis of many cytokines, including
were derived as described previously (Huber et al., 1998a). By 8IL-6 (Kitaura et al., 2000; Marquardt and Walker, 2000),
weeks in culture, greater than 99% of the cells were c-kit and FcRIand directly upregulates the antiapoptotic protein
positive, as assessed by fluorescein isothiocyanate (FITC)-labeledBcl-XL (Khoshnan et al., 2000). As well, both p38 and JNK anti-c-kit antibodies (PharMingen, Mississaga, Canada) and FITC-
have been shown to enhance inflammatory cytokine labeled IgE (anti-erythropoietin 26), respectively (Huber et al., 1998a,
synthesis (Kozawa et al., 1999), the latter via upregulat- 1998b).
ing c-Jun (Kitaura et al., 2000). Related to this, our finding
that IgE-induced IL-6 secretion is inhibited by LY294002, BMMC Stimulation, Immunoprecipitation, and Western Blotting
To treat BMMCs  IgE alone, the cells were starved (i.e., incubatedPD98059, and SB203580 implicates the PI-3-kinase/
without IL-3) for 4 hr at 37C in IMDM  10% FCS  150 M MTGPKB, ERK, and p38 pathways in this process.
and then washed three times with IMDM  0.1% BSA and resus-Cytokine production has also been shown to be regu-
pended in IMDM  0.1% BSA for 5 min at 37C before adding 5–20
lated in mast cells, at the level of secretion, and the
g/ml anti-DNP IgE (i.e., monoclonal anti-dinitrophenyl [DNP] clone
prolonged signaling induced by IgE may preferentially SPE-7 IgE [Sigma]) for the indicated times. To stimulate with IgE 
enhance this step as well. Specifically, Baumgartner et Ag, BMMCs were preloaded with 5 g/ml IgE for 4 hr in IMDM 
10% FCS  150 M MTG, washed three times to remove unboundal. (1994) found there is an Ag-induced calcium- and
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IgE, and then resuspended in IMDM  0.1% BSA for 5 min at 37C acetate (10 M) precipitated DNA was separated by electrophoresis
on a 1% agarose gel.before adding 20 ng/ml DNP-HSA (30–40 moles DNP/mole human
serum albumin; Sigma) for the indicated times. The cells were then
washed with 4C PBS and solubilized either by boiling for 2 min Removal of IgE from BMMC-Conditioned Medium
with SDS-sample buffer (using 5 
 105 BMMCs/sample for total cell DNP-beads were made by coupling 2,4-dinitrobenzenesulfonic acid
lysates) or with 1% TX100 (using 10 
 106 BMMCs/sample) in 1 ml (Aldrich, Oakville, ON) to hydrazide CarboLinkTM Coupling Gel
of 4C phosphorylation solubilization buffer (Liu et al., 1994) and (Pierce, Rockford, IL) as described in Inman and Dintzis (1969). In
subjected to immunoprecipitation and Western blotting as de- brief, 1 ml of gel was washed in saturated Na2B4O7·10H20 (pH 9.3)
scribed (Liu et al., 1994). Polyclonal antibodies against the phospho- and incubated at 23C for 1 hr with 2.5 ml of 20 mg/ml 2,4-dinitroben-
S473 and phospho-T308 forms of PKB, PKB, the phospho-T180/ zenesulfonic acid in Na2B4O7·10H20. DNP-bead preparations were
Y182 p38, and the phospho-T202/Y204 Erk 1/2 were from New En- then washed consecutively with 0.1 N acetic acid, water, and 0.1 N
gland BioLabs, Inc. (Mississauga, Canada). Polyclonal antibodies NH4OH, followed by storage in PBS  0.02% azide (Truffa-Bachi
against Bcl-XL and Shc were from Transduction Laboratories (Lex- and Wofsy, 1970). IgE was depleted from 3 day conditioned media
ington, KY). The anti-Erk1 antibody (Erk-1-CT) was a gift from Dr. by two consecutive 1 hr incubations at 23C, with 100 l DNP-
S. Pelech (University of British Columbia). 4G10 beads used for beads/ml conditioned media.
immunoprecipitation were from Upstate Biotechnology (UBI, Lake
Placid, NY).
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